-
Researchers generate a stem cell-based model to study an ultra-rare disease that causes childhood parkinsonism
Researchers from the Institut de Recerca Sant Joan de Déu (IRSJD), the Bellvitge Biomedical Research Institute (IDIBELL), Sant Pau Research Institute (IIB Sant Pau) and the UB generated the first model of this disease that reproduce patients' characteristics and response to treatment.
-
IRSJD researchers have discovered an intergenerational inheritance mechanism in mouse models of childhood obesity
A study led by Dr. Josep Jiménez-Chillaron, a researcher at the Institut de Recerca Sant Joan de Déu and the University of Barcelona, suggests that hepatic steatosis could be intergenerationally inherited through paternal germ line microRNAs. Hepatic steatosis is a condition that is associated with childhood obesity. The results of this study have been published in the scientific journal Nutrients.
-
An early diagnosis and some diet changes can decrease the risk of severe symptoms in children with BCKDK metabolic deficiency
The research, under the leadership of Dr. Àngels García-Cazorla at the Institut de Recerca Sant Joan de Déu, has demonstrated that early identification of this disease is possible through the standard neonatal screening test, also known as the heel prick test.
-
Artificial intelligence tool to predict neurodevelopmental progress of infants with low birth weight
Dr Carles Escera receives support from the Bosch i Gimpera Foundation to develop the project Artificial intelligence tool to predict neurodevelopmental progress of infants with low birth weight.
-
Experts in nanomedicine come together to tackle rare diseases
The fourth edition of the "Nanorare Disease Day" event was held on February 28th, in collaboration between the Institut de Recerca Sant Joan de Déu de Barcelona and NanomedSpain, on World Rare Disease Day.
-
Researchers at IRSJD develop a method to predict the efficacy of a potent nanomedicine in a severe childhood cancer
Researchers at IRSJD have developed a method that predicts the anticancer efficacy of nab-paclitaxel, a well-known nanomedicine, in mouse models, for treatment of Ewing sarcoma, a severe cancer affecting the bones and soft tissue of children and adolescents.
-
Dr. Joan Comella, new director of the Institut de Recerca Sant Joan de Déu
The Governing Council of the Institute de Recerca Sant Joan de Déu (IRSJD) has appointed Dr. Joan Comella as director of the Institute. We thank Dr. Francesc Palau for his years of dedication to the management.
-
Pro-inflammatory alterations identified in persons with non-specific low back pain
A study led by the Psychological Research on Fibromyalgia and Chronic Pain Group (AGORA Group) of the Institut de Recerca Sant Joan de Déu (IRSJD) · Parc Sanitari Sant Joan de Déu and the Universitat Autònoma de Barcelona (UAB) contributes new evidence on the immune-inflammatory state in non-specific low back pain.
-
A new European project is starting to create a European Youth Cancer Survivors Network
The EU-funded project "EU-CAYAS-NET" will develop a "European Youth Cancer Survivors Network" alongside an interactive virtual platform, with Institut de Recerca Sant Joan de Déu participation.
